Bayer HealthCare Animal

WO 2024052517

USAGE MÉDICAL D'ANTICORPS ANTI-CCR8 ET PROGRAMME DE DOSAGE

Expires Wed Mar 09 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

CN 117186084

Pranlerivir sulfonate, and pharmaceutical preparation, preparation method and application thereof in treatment of herpes virus

Expires Thu Dec 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

CN 115348859

Ophthalmic formulations comprising n-[5-(aminosulfonyl)-4-methyl-1, 3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl) phenyl] acetamide hemihydrate

Expires Mon Nov 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

CN 115003329

Parapoxvirus for conditioning and treating coronavirus infections

Expires Thu Aug 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

BR 112021015776

Edição de gene para hemofilia a com expressão de fator viii melhorada

Expires Mon Nov 04 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2021152186

ANTICORPS CCR8 POUR APPLICATIONS THÉRAPEUTIQUES

Expires Wed Jul 31 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

DE 102019218587

Kontrastmittelbasierte Gefäßdarstellung

Expires Tue May 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

DE 102019218589

Simultane Bilddarstellung von zwei unterschiedlichen funktionellen Bereichen

Expires Tue May 28 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 3752616

ZUSAMMENSETZUNGEN UND VERFAHREN ZUR GENEDITIERUNG DURCH TARGETING VON FIBRINOGEN-ALPHA

Expires Tue Dec 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2020384125

GENE EDITING FOR HEMOPHILIA A WITH IMPROVED FACTOR VIII EXPRESSION

Expires Wed Dec 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 3728594

MATERIALIEN UND VERFAHREN ZUR BEHANDLUNG DES USHER-SYNDROMS TYP 2A

Expires Tue Oct 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2020318108

MATERIALS AND METHODS FOR TREATMENT OF USHER SYNDROME TYPE 2A AND/OR NON-SYNDROMIC AUTOSOMAL RECESSIVE RETINITIS PIGMENTOSA (ARRP)

Expires Wed Oct 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3121191

CAS9 DE CODAGE D'ARNM OPTIMISE DESTINE A ETRE UTILISE DANS DES LNP

Expires Wed May 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3118090

COMPOSITIONS ET PROCEDES POUR EDITION DU GENOME A MEDIATION PAR NHEJ

Expires Wed May 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3116885

COMPOSITIONS ET METHODES D'ADMINISTRATION DE TRANSGENE

Expires Wed Apr 18 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

EP 3630112

KOMBINATION AUS REGORAFENIB UND PD-1/PD-L1(2)-INHIBITOREN ZUR BEHANDLUNG VON KREBS

Expires Tue Apr 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3098014

CELLULES CAR-T ANTI-BCMA POUR DEPLETION DE CELLULES PLASMATIQUES

Expires Wed Oct 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3097885

PROCEDES ET COMPOSITIONS D'EPUISEMENT DE LYMPHOCYTES T CYTOTOXIQUES

Expires Wed Oct 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3088180

COMPOSITIONS ET METHODES POUR L'EDITION GENIQUE PAR CIBLAGE DE LA TRANSFERRINE

Expires Wed Jul 13 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3084733

MATERIELS ET PROCEDES POUR TRAITER LA DYSTROPHIE DES CONES ET DES BATONNETS AUTOSOMIQUE DOMINANTE

Expires Wed Jun 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2019153441

MATERIALS AND METHODS FOR TREATMENT OF AUTOSOMAL DOMINANT RETINITIS PIGMENTOSA

Expires Wed May 18 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

CA 3079172

COMPOSITIONS ET METHODES POUR L'EDITION GENIQUE POUR L'HEMOPHILIE A

Expires Wed Apr 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2018227427

DÉRIVÉS DE DIAZÉPANE PONTÉS SUBSTITUÉS ET LEUR UTILISATION

Expires Wed Dec 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2018128828

NOUVEAUX MIMÉTIQUES D'HEPCIDINE ET LEURS UTILISATIONS

Expires Wed Jul 07 2038 00:00:00 GMT+0000 (Coordinated Universal Time)